We are live on ! Find out more
RPRX

Repros Therapeutics Inc.
RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

92 hedge funds and large institutions have $577M invested in Repros Therapeutics Inc. in 2013 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 28 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 10

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

42% more call options, than puts

Call options by funds: $81M | Put options by funds: $57.2M

39% more capital invested

Capital invested by funds: $414M → $577M (+$163M)

25% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 28

14% more funds holding

Funds holding: 81 → 92 (+11)

Holders
92
Holders Change
+11
Holders Change %
+13.58%
% of All Funds
2.98%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
21
Increased
35
Reduced
28
Closed
10
Calls
$81M
Puts
$57.2M
Net Calls
+$23.8M
Net Calls Change
+$34.1M

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$27.9M
2
Citadel Advisors
Citadel Advisors
Florida
+$14M
3
State Street
State Street
Massachusetts
+$9.95M
4
Invesco
Invesco
Georgia
+$8.51M
5
Franklin Resources
Franklin Resources
California
+$5.46M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$22.4M
2
QF
QVT Financial
New York
-$20.1M
3
PHS
PFM Health Sciences
California
-$12.1M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$6.54M
5
KCM
Kingdon Capital Management
New York
-$6.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$3.71M +$820K +38,271 +38%
Millennium Management
27
Millennium Management
New York
$3.42M -$3.49M -162,815 -56%
Bank of America
28
Bank of America
North Carolina
$3.13M +$69.4K +3,239 +3%
Balyasny Asset Management
29
Balyasny Asset Management
Illinois
$2.94M -$992K -46,286 -30%
PP
30
PDT Partners
New York
$2.79M +$2.23M +103,945 New
Geode Capital Management
31
Geode Capital Management
Massachusetts
$2.75M +$549K +25,640 +33%
GAI
32
General American Investors
New York
$2.75M +$2.2M +102,500 New
GACM
33
Green Arrow Capital Management
New York
$2.68M -$542K -25,275 -20%
EI
34
EAM Investors
California
$2.56M +$2.05M +95,476 New
SC
35
Sophrosyne Capital
New York
$2.5M -$3.69M -172,000 -65%
TCIM
36
TIAA CREF Investment Management
New York
$2.4M +$290K +13,547 +18%
RFC
37
Russell Frank Company
Washington
$1.94M +$1.5M +69,818 New
ST
38
Spot Trading
Illinois
$1.91M +$1.53M +71,360 New
BIM
39
BlackRock Investment Management
Delaware
$1.72M +$303K +14,128 +28%
Allianz Asset Management
40
Allianz Asset Management
Germany
$1.69M +$1.35M +63,060 New
CII
41
CR Intrinsic Investors
Connecticut
$1.68M -$1.34M -62,300 -50%
JP Morgan Chase
42
JP Morgan Chase
New York
$1.6M -$3.02M -141,048 -70%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$1.47M +$193K +9,011 +20%
CS
44
Credit Suisse
Switzerland
$1.4M +$491K +22,931 +78%
Ameriprise
45
Ameriprise
Minnesota
$1.11M +$866K +40,431 +3,392%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$1.1M +$184K +8,600 +26%
Deutsche Bank
47
Deutsche Bank
Germany
$1.03M -$1.2M -55,945 -59%
AQR Capital Management
48
AQR Capital Management
Connecticut
$948K -$6.54M -305,200 -90%
Charles Schwab
49
Charles Schwab
California
$886K +$129K +6,000 +22%
TA
50
Teachers Advisors
New York
$838K +$112K +5,216 +20%
1
2
3 4 5

RPRX Hedge Fund Activity: Q3 2013 in Review

92 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q3 2013, worth a combined $577M — up 39% from $414M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RPRX positions and 10 closed out — a net gain of 11 holders — while 35 added to existing stakes and 28 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $27.9M. The largest seller was Jennison Associates, cutting an estimated $22.4M.

  • 92 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q3 2013, up from 81 in Q2 2013.
  • Funds reported $577M of Repros Therapeutics Inc. stock for Q3 2013, up 39% quarter-over-quarter.
  • 21 funds opened new Repros Therapeutics Inc. positions in Q3 2013 and 10 closed out, a net change of +11 holders.
  • The largest Repros Therapeutics Inc. buyer in Q3 2013 was Perceptive Advisors, an estimated $27.9M added.
  • The largest Repros Therapeutics Inc. seller in Q3 2013 was Jennison Associates, an estimated $22.4M sold.

Based on aggregated 13F filings for Q3 2013.